177Lu-Dotatate for midgut neuroendocrine tumours

被引：5
|
作者：
Burki, Talha Khan
机构：
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 02期
关键词：
D O I：
10.1016/S1470-2045(17)30042-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E74 / E74
页数：1
相关论文
共 50 条
  • [41] NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE: Efficacy and Safety Results
    Strosberg, J.
    Wolin, E.
    Chasen, B.
    Kulke, M.
    Bushnell, D.
    Caplin, M.
    Baum, R.
    Kunz, P.
    Hobday, T.
    Hendifar, A.
    Oberg, K.
    Sierra, Lopera M.
    Kwekkeboom, D.
    Ruszniewski, P.
    Krenning, E.
    [J]. NEUROENDOCRINOLOGY, 2016, 103 : 95 - 95
  • [42] NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate: Efficacy and Safety Results
    Strosberg, J.
    Wolin, E.
    Chasen, B.
    Kulke, M.
    Bushnell, D.
    Caplin, M.
    Baum, R. P.
    Kunz, P.
    Hobday, T.
    Hendifar, A.
    Oberg, K.
    Sierra, M. Lopera
    Kwekkeboom, D.
    Ruszniewski, P.
    Krenning, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S121 - S121
  • [43] NETTER-1 phase III: Efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-DOTATATE
    Strosberg, Jonathan R.
    Wolin, Edward M.
    Chasen, Beth
    Kulke, Matthew H.
    Bushnell, David L.
    Caplin, Martyn E.
    Baum, Richard P.
    Hobday, Timothy J.
    Hendifar, Andrew Eugene
    Oberg, Kjell E.
    Sierra, Maribel Lopera
    Kwekkeboom, Dik J.
    Ruszniewski, Philippe B.
    Krenning, Eric
    Kunz, Pamela L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] NETTER-1 phase III: efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate
    Strosberg, J.
    Wolin, E.
    Chasen, B.
    Kulke, M.
    Bushnell, D.
    Chaplin, M.
    Baum, R.
    Kunz, P.
    Hobday, T.
    Oberg, K.
    Sierra, M. Lopera
    Kwekkeboom, D.
    Ruszniewski, P.
    Krenning, E.
    Hendifar, A.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 121 - 121
  • [45] Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours
    Stefano Severi
    Oriana Nanni
    Lisa Bodei
    Maddalena Sansovini
    Annarita Ianniello
    Stefania Nicoletti
    Emanuela Scarpi
    Federica Matteucci
    Laura Gilardi
    Giovanni Paganelli
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 881 - 888
  • [46] Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours
    Severi, Stefano
    Nanni, Oriana
    Bodei, Lisa
    Sansovini, Maddalena
    Ianniello, Annarita
    Nicoletti, Stefania
    Scarpi, Emanuela
    Matteucci, Federica
    Gilardi, Laura
    Paganelli, Giovanni
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (06) : 881 - 888
  • [47] Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II study
    Partelli, Stefano
    Landoni, Luca
    Bartolomei, Mirco
    Zerbi, Alessandro
    Grana, Chiara Maria
    Boggi, Ugo
    Butturini, Giovanni
    Casadei, Riccardo
    Salvia, Roberto
    Falconi, Massimo
    [J]. BRITISH JOURNAL OF SURGERY, 2024, 111 (09)
  • [48] Radiographic Predictors of Response to 177Lu-DOTATATE
    Mulvey, Claire K.
    Bergsland, Emily K.
    Lindsay, Sheila
    Hope, Thomas A.
    [J]. PANCREAS, 2019, 48 (03) : 446 - 446
  • [49] 177Lu-DOTATATE in older patients with metastatic neuroendocrine tumours: safety, efficacy and health-related quality of life
    Luohai Chen
    Shaunak Navalkissoor
    Ann-Marie Quigley
    Gopinath Gnanasegaran
    Dalvinder Mandair
    Christos Toumpanakis
    Martyn E. Caplin
    Aimee R. Hayes
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 3582 - 3594
  • [50] Method dependence, observer variability and kidney volumes in radiation dosimetry of 177Lu-DOTATATE therapy in patients with neuroendocrine tumours
    Sandström M.
    Ilan E.
    Karlberg A.
    Johansson S.
    Freedman N.
    Garske-Román U.
    [J]. EJNMMI Physics, 2 (1) : 1 - 13
12345